» Articles » PMID: 24012527

Natural Product Vindoline Stimulates Insulin Secretion and Efficiently Ameliorates Glucose Homeostasis in Diabetic Murine Models

Overview
Date 2013 Sep 10
PMID 24012527
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Ethnopharmacological Relevance: Catharanthus roseus (L). Don (Catharanthus roseus) is a traditional anti-diabetic herb widely used in many countries, and the alkaloids of Catharanthus roseus are considered to possess hypoglycemic ability.

Aim Of The Study: To systematically investigate the potential anti-diabetic effects and the underlying anti-diabetic mechanisms of vindoline, one of the alkaloids in Catharanthus roseus.

Materials And Methods: The regulation of vindoline against the glucose-stimulated insulin secretion (GSIS) was examined in insulinoma MIN6 cells and primary pancreatic islets. Insulin concentration was detected by Elisa assay. Diabetic models of db/db mice and type 2 diabetic rats induced by high-fat diet combining with streptozotocin (STZ/HFD-induced type 2 diabetic rats) were used to evaluate the anti-diabetic effect of vindoline in vivo. Daily oral treatment with vindoline (20mg/kg) to diabetic mice/rats for 4 weeks, body weight and blood glucose were determined every week, oral glucose tolerance test (OGTT) was performed after 4 weeks.

Results: Vindoline enhanced GSIS in both glucose- and dose-dependent manners (EC50 = 50 μM). It was determined that vindoline acted as a Kv2.1 inhibitor able to reduce the voltage-dependent outward potassium currents finally enhancing insulin secretion. It protected β-cells from the cytokines-induced apoptosis following its inhibitory role in Kv2.1. Moreover, vindoline (20mg/kg) treatment significantly improved glucose homeostasis in db/db mice and STZ/HFD-induced type 2 diabetic rats, as reflected by its functions in increasing plasma insulin concentration, protecting the pancreatic β-cells from damage, decreasing fasting blood glucose and glycated hemoglobin (HbA1c), improving OGTT and reducing plasma triglyceride (TG).

Conclusion: Our findings suggested that vindoline might contribute to the anti-diabetic effects of Catharanthus roseus, and this natural product may find its more applications in the improvement of β-cell dysfunction and further the potential treatment of type 2 diabetes.

Citing Articles

Vindoline is a key component of Catharanthus roseus leaf juice extract prepared through an Ayurveda-based method for ameliorating insulin-resistant type 2 diabetes.

Singh P, Singh D, Patel M, Binwal M, Kaushik A, Mall M Protoplasma. 2025; .

PMID: 39794517 DOI: 10.1007/s00709-024-02026-w.


Evaluation of the impact of vindoline, an active components of Catharanthus roseus, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs.

Zhang Y, Niu H, Liu J, Xie W, Jin Y, Zhang Z PLoS One. 2023; 18(8):e0289656.

PMID: 37535556 PMC: 10399899. DOI: 10.1371/journal.pone.0289656.


Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts.

Shijina B, Radhika A, Sherin S, Biju P Nutrients. 2023; 15(13).

PMID: 37447192 PMC: 10343616. DOI: 10.3390/nu15132865.


Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?.

Lodato M, Plaisance V, Pawlowski V, Kwapich M, Barras A, Buissart E Cells. 2023; 12(6).

PMID: 36980281 PMC: 10047094. DOI: 10.3390/cells12060940.


Serpentine Enhances Insulin Regulation of Blood Glucose through Insulin Receptor Signaling Pathway.

Wang Y, Liu G, Liu X, Chen M, Zeng Y, Li Y Pharmaceuticals (Basel). 2023; 16(1).

PMID: 36678512 PMC: 9861791. DOI: 10.3390/ph16010016.